| Typicality: | 0.397 |
| Saliency: | 0.549 |
| in the us | 4 | location |
| in france | 4 | location |
| schedule iii | 2 | degree |
| ketamine → be → a schedule iv drug | 6 |
| ketamine → be → schedule iii controlled substance | 4 |
| ketamine → be → a schedule iii drug | 4 |
| ketamine → be → a schedule i drug | 3 |
| ketamine → be → a schedule ii drug | 3 |
| negative | neutral | positive |
| 0.594 | 0.391 | 0.015 |
| Raw frequency | 20 |
| Normalized frequency | 0.549 |
| Modifier score | 0.500 |
| Perplexity | 15.767 |